Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount  |
|---|---|---|---|---|---|---|
| SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
| Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | FDA | $41,500,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
| Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
| Endo Health Solutions | Endo International | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
| Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2012 | private lawsuit-state | $39,000,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $37,000,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
| Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
| Momenta Pharmaceuticals Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $35,000,000 |
| UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
| Watson, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
| Alere Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2018 | DOJ_CIVIL | $33,200,000 |
| Genzyme Corporation | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
| Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
| Sandoz, Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
| Mylan N.V. | Viatris | pharmaceuticals | investor protection violation | 2019 | SEC | $30,000,000 |
| Wyeth-Ayerst Laboratories Division | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
| Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
| Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
| Merck Sharp & Dohme Corp | Merck | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
| Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
| Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
| Apotex Corp. | Apotex Corp. | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
| Purdue Pharma | Purdue Pharma | pharmaceuticals | drug or medical equipment safety violation | 2015 | KY-AG | $24,000,000 |
| AbbVie Inc. | AbbVie | pharmaceuticals | consumer protection violation | 2020 | CA-INS | $24,000,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
| Roussel Uclaf S.A. | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
| Mylan Laboratories Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
| Medicis Pharmaceutical Corp. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $23,000,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
| Merck, Sharp & Dohme Corp. | Merck | pharmaceuticals | consumer protection violation | 2014 | private lawsuit-federal | $23,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
| Biogen, Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Eisai Company | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $21,280,356 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
| DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
| Celgene Corp. | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
| GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $20,000,000 |
| Clovis Oncology Inc. | Clovis Oncology | pharmaceuticals | investor protection violation | 2018 | SEC | $20,000,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
| Impax Laboratories, Inc. | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $20,000,000 |
| Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
| Sanofi-Pasteur | Sanofi | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
| Merck | Merck | pharmaceuticals | water pollution violation | 2007 | EPA | $19,750,000 |
| Pharmacia & Upjohn Company Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $19,700,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
| Purdue Pharma | Purdue Pharma | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | $19,500,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
| Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $19,000,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $18,960,210 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Acclarent Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
| Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
| Bausch & Lomb | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
| Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
| St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
| Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
| Purdue Pharma L.P. | Purdue Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | private lawsuit-federal | $16,000,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| Geneva Pharmaceuticals | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| Elan Corporation, plc | Perrigo | pharmaceuticals | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | investor protection violation | 2017 | SEC | $15,000,000 |
| Pharmacia & Upjohn Company LLC | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $15,000,000 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $15,000,000 |
| Impax Laboratories, Inc. | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $15,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Aventis Pharmaceutical L.P. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
